References
1. Sweeney, L.G. et al. (2005) Int J Pharm. 305:180-185. 2. Mani, N. et al., (2006) Antimicrobial Agents and Chemotherapy 50:1228-1237. 3. Callegan, M.C. et al., (2006) Curr Eye Res. 31:693-702. 4. Hoti, S. et al., (2006) Molecular Therapy (2006) 14:768-778. 5. Ely, L et al., (2007) Eur J Pharm Biopharm. 65:346-353. 6. Hoti, S. et al., (2010) Cancer Gene Therapy 17; 585-597.USBio References
US Biological application references: 1. Sweeney, L.G. et al. (2005) Int J Pharm. 305:180-185. 2. Mani, N. et al., (2006) Antimicrobial Agents and Chemotherapy 50:1228-1237. 3. Callegan, M.C. et al., (2006) Curr Eye Res. 31:693-702. 4. Hoti, S. et al., (2006) Molecular Therapy (2006) 14:768-778. 5. Ely, L et al., (2007) Eur J Pharm Biopharm. 65:346-353. 6. Hoti, s. et al., (2010) Cancer Gene Therapy 17; 585-597.